Genotyping Assay in Digital PCR Conditions for the Detection of IDH1 Mutation in PlasmaThursday, 19 April 2012 at 14:15 Add to Calendar ▼2012-04-19 14:15:002012-04-19 15:15:00Europe/LondonGenotyping Assay in Digital PCR Conditions for the Detection of IDH1 Mutation in PlasmaSELECTBIOenquiries@selectbiosciences.com The use of circulating tumor DNA as a biomarker is a challenge, particularly in regards to brain tumors. Through the use of COLD PCR and digital PCR, we were able not only to highlight the presence of circulating tumor DNA in patients with gliomas, but also to validate the presence of the most frequent mutation in this disease. The strong prognostic impact of this change now allows us to propose an alternative technique for imaging in terms of diagnostics, but also for the prognosis of these tumors. |